臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51776835 線上人數 : 1013 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jeng shiuan"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 1-8 / 8 (共1頁)
1
每頁顯示[10|25|50]項目

機構	日期	題名	作者
國立成功大學	2023-08-21	Low neutrophil-to-lymphocyte ratio predicts overall survival benefit in advanced NSCLC patients with low PD-L1 expression and receiving chemoimmunotherapy	Chen;Chian-Wei;Lin;Chien-Yu;Tsai;Jeng-Shiuan;Lin;Chia-Yin;Chang;Chao-Chun;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung
國立成功大學	2023-07	Chemotherapy outcomes in EGFR-TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study	Lin;Chien-Yu;Hu;Chia-Hao;Hsu;Chia-Fu;Tsai;Jeng-Shiuan;Chen;Chian-Wei;Lin;Chia-Yin;Chang;Chao-Chun;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung
國立成功大學	2023-05-16	Cigarette smoke increases susceptibility of alveolar macrophages to SARS-CoV-2 infection through inducing reactive oxygen species-upregulated angiotensin-converting enzyme 2 expression	Kuo;Chin-Wei;Su;Po-Lan;Huang;Tang-Hsiu;Lin;Chien-Chung;Chen;Chian-Wei;Tsai;Jeng-Shiuan;Liao;Xin-Min;Chan;Tzu-Yi;Shieh;Chi-Chang
國立成功大學	2023-03-9	Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs	Chu;Chang-Yao;Lin;Chien-Yu;Lin;Chien-Chung;Li;Chien-Feng;Wu;Shang-Yin;Tsai;Jeng-Shiuan;Yang;Szu-Chun;Chen;Chian-Wei;Lin;Chia-Yin;Chang;Chao-Chun;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Su;Wu-Chou
國立成功大學	2023	Navigating the challenges of invasive pulmonary aspergillosis in lung cancer treatment: a propensity score study	Kuo;Chin-Wei;Lin;Chien-Yu;Wei;Sheng-Huan;Chou;Yun-Tse;Chen;Chian-Wei;Tsai;Jeng-Shiuan;Su;Po-Lan;Lin;Chien-Chung
國立成功大學	2022-11	Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio	Tsai;Jeng-Shiuan;Wei;Sheng-Huan;Chen;Chian-Wei;Yang;Szu-Chun;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2022-02-28	The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy	Su;Po-Lan;Chen;Jung-Yueh;Chu;Chang-Yao;Chen;Yi-Lin;Chen;Wan-Li;Lin;Kuan-Yu;Ho;Chung-Liang;Tsai;Jeng-Shiuan;Yang;Szu-Chun;Chen;Chian-Wei;Wu;Yi-Lin;Tseng;Yau-Lin;Chang;Chao-Chun;Yen;Yi-Ting;Lin;Chia-Ying;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學	2021-09	EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis	Tsai;Jeng-Shiuan;Su;Po-Lan;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou

顯示項目 1-8 / 8 (共1頁)
1
每頁顯示[10|25|50]項目